Serial high-sensitivity troponin I monitoring as a prognostic marker in acute ischemic stroke
DOI:
https://doi.org/10.15584/ejcem.2026.1.20Keywords:
acute ischemic stroke, cardiac mortality, high-sensitivity troponin IAbstract
Introduction and aim. Acute ischemic stroke (AIS) is a complex disease with multifactorial etiologies, often masking underlying cardiovascular morbidities that contribute to clinical outcomes. This study explored the role of serial high-sensitivity troponin I (hs-TnI) monitoring in AIS patients as a prognostic marker of cardiovascular morbidity and mortality. The results offer substantial information on the relationship between hs-TnI elevations and clinical, electrocardiographic (ECG), echocardiographic (ECHO), and angiographic parameters in patients with AIS.
Material and methods. A prospective observational study was conducted on 60 patients with AIS in a tertiary care center, Tamil Nadu. Hs-TnI levels were measured at the time of admission and after 48 h together with ECG, ECHO. Angiographic evaluations were done in patients with elevated hs-TnI at 48 h after admission.
Results. Among the study population, hs-TnI levels increased significantly from 11.7% at admission to 20% after 48 h (p=0.02).Logistic regression showed hs-TnI at 48 h predicted mortality (odds ratio [OR]=28.5, 95% confidence interval [CI]: 5.9‒137.1, p<0.001) and coronary artery disease (CAD) (OR=48.2, 95% CI: 9.8‒236.5, p<0.001).
Conclusion. Serial monitoring of hs-TnI in AIS patients revealed its potential role in the identification of culprit lesions on coronary angiogram, which is correlated with the presence of CAD and mortality.
Downloads
References
Huang X, Lu Z, Li T, et al. Comorbidity patterns in patients with first-ever acute ischemic stroke and their associations with functional outcomes. Neuroepidemiology. 2025;59(1):1-13. doi:10.1159/000544170
König IR, Ziegler A, Bluhmki E, et al. Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke. 2008;39(6):1821-1826. doi:10.1161/STROKEAHA.107.505867
Lip GYH, Lane DA, Lenarczyk R, et al. Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke. Eur Heart J. 2022;43(26):2442-2460. doi:10.1093/eurheartj/ehac245
Ion A, Stafie C, Mitu O, et al. Biomarkers utility: at the borderline between cardiology and neurology. J Cardiovasc Dev Dis. 2021;8(11):141. doi:10.3390/jcdd8110139
Raber I, McCarthy CP, Januzzi JL Jr. A test in context: interpretation of high-sensitivity cardiac troponin assays in different clinical settings. J Am Coll Cardiol. 2021;77(10):1357-1367. doi:10.1016/j.jacc.2021.01.011
Scheitz JF, Sposato LA, Schulz-Menger J, Nolte CH, Backs J, Endres M. Stroke–heart syndrome: recent advances and challenges. J Am Heart Assoc. 2022;11(17):e026528. doi:10.1161/JAHA.122.026528
Scheitz JF, Nolte CH, Doehner W, Hachinski V, Endres M. Stroke–heart syndrome: clinical presentation and underlying mechanisms. Lancet Neurol. 2018;17(12):1109-1120. doi:10.1016/S1474-4422(18)30336-3
Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264. doi:10.1016/j.jacc.2018.08.1038
Lazar DR, Lazar FL, Homorodean C, et al. High-sensitivity troponin: a review on characteristics, assessment, and clinical implications. Dis Markers. 2022;2022:9713326. doi:10.1155/2022/9713326
Gulia A, Srivastava M, Kumar P. Elevated troponin levels as a predictor of mortality in patients with acute stroke: a systematic review and meta-analysis. Front Neurol. 2024;15:1351925. doi:10.3389/fneur.2024.1351925
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46-e99. doi:10.1161/STR.0000000000000158
Vilela E, Bastos J, Rodrigues R, Nunes JP. High-sensitivity troponin after running: a systematic review. Neth J Med. 2014;72(1):5-9.
Jensen JK, Atar D, Mickley H. Mechanism of troponin elevations in patients with acute ischemic stroke. Am J Cardiol. 2007;99(6):867-870. doi:0.1016/j.amjcard.2006.10.052
Leite L, Matos P, Leon-Justel A, et al. High-sensitivity troponins: potential biomarkers of cardiovascular risk for primary prevention. Front Cardiovasc Med. 2022;9:1054959. doi:10.3389/fcvm.2022.1054959
Scheitz JF, Stengl H, Nolte CH, Landmesser U, Endres M. Neurological update: use of cardiac troponin in patients with stroke. J Neurol. 2021;268(6):2284-2292. doi:10.1007/s00415-020-10349-w
Bahadur K, Ijaz A, Salahuddin M, Alam A. Determination of high-sensitive cardiac troponin I 99th percentile upper reference limits in a healthy Pakistani population. Pak J Med Sci. 2020;36(6):1303-1307. doi:10.12669/pjms.36.6.2328
Kosaraju A, Goyal A, Grigorova Y, Makaryus AN. Left Ventricular Ejection Fraction. StatPearls. Treasure Island, FL: StatPearls Publishing; 2025.
Armstrong WF, Ryan T. Feigenbaum’s Echocardiography. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012:1-1676.
Writing Committee Members, Gulati M, Levy PD, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;78(22):e187-e285. doi:10.1016/j.jacc.2021.07.053
ABIM Laboratory Test Reference Ranges - January 2022. Study notes Radioimmunoassay. Docsity. https://www.docsity.com/en/docs/abim-laboratory-test-reference-ranges-january-2022/8916253/. Accessed October 28, 2025.
Norris JW, Hachinski VC, Myers MG, Callow J, Wong T, Moore RW. Serum cardiac enzymes in stroke. Stroke. 1979;10(5):548-553. doi:10.1161/01.STR.10.5.548
Rosso M, Ramaswamy S, Mulatu Y, et al. Rising cardiac troponin: a prognostic biomarker for mortality after acute ischemic stroke. J Am Heart Assoc. 2024;13(4):e032922. doi:10.1161/JAHA.123.032922
Nolte CH, von Rennenberg R, Litmeier S, et al. Type 1 myocardial infarction in patients with acute ischemic stroke. JAMA Neurol. 2024;81(7):703-711. doi:10.1001/jamaneurol.2024.1552
Fure B, Bruun Wyller T, Thommessen B. Electrocardiographic and troponin T changes in acute ischemic stroke. J Intern Med. 2006;259(6):592-597. doi:10.1111/j.1365-2796.2006.01639.x
Mochmann HC, Scheitz JF, Petzold GC, et al. Coronary angiographic findings in acute ischemic stroke patients with elevated cardiac troponin: the troponin elevation in acute ischemic stroke (TRELAS) study. Circulation. 2016;133(13):1264-1271. doi:10.1161/CIRCULATIONAHA.115.018547
Wang L, Ma L, Ren C, et al. Stroke–heart syndrome: current progress and future outlook. J Neurol. 2024;271(8):4813-4825. doi:10.1007/s00415-024-12480-4
von Rennenberg R, Herm J, Krause T, et al. Elevation of cardiac biomarkers in stroke is associated with pathological findings on cardiac MRI: results of the Heart and Brain Interfaces in Acute Stroke study. Int J Stroke. 2023;18(2):180-186. doi:10.1177/17474930221095698
Lasek-Bal A, Kowalewska-Twardela T, Gąsior Z, et al. The significance of troponin elevation for the clinical course and outcome of first-ever ischemic stroke. Cerebrovasc Dis. 2014;38(3):212-218. doi:10.1159/000365839
Fan Y, Jiang M, Gong D, Man C, Chen Y. Cardiac troponin for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis. Biosci Rep. 2018;38(2):BSR20171676. doi:10.1042/BSR20171178
Scheitz JF, Lim J, Broersen LH, et al. High-sensitivity cardiac troponin T and recurrent vascular events after first ischemic stroke. J Am Heart Assoc. 2021;10(10):e018326. doi:10.1161/JAHA.120.018326
Di Angelantonio E, Fiorelli M, Toni D, et al. Prognostic significance of admission levels of troponin I in patients with acute ischemic stroke. J Neurol Neurosurg Psychiatry. 2005;76(1):76-81.
Sörös P, Hachinski V. Cardiovascular and neurological causes of sudden death after ischemic stroke. Lancet Neurol. 2012;11(2):179-188. doi:0.1016/S1474-4422(11)70291-5
Kolin A, Norris JW. Myocardial damage from acute cerebral lesions. Stroke. 1984;15(6):990-993. doi:10.1161/01.STR.15.6.990
Johansen MC, von Rennenberg R, Nolte CH, et al. Role of cardiac biomarkers in stroke and cognitive impairment. Stroke. 2024;55(9):2376-2384. doi:10.1161/STROKEAHA.123.044143
Krause T, Werner K, Fiebach JB, et al. Stroke in right dorsal anterior insular cortex is related to myocardial injury. Ann Neurol. 2017;81(4):502-511. doi:10.1002/ana.24906
Iltumur K, Yavavli A, Apak I, Ariturk Z, Toprak N. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke. Am Heart J. 2006;151(5):1115-1122. doi:10.1016/j.ahj.2005.05.022
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
